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Donor site complications, following microvascular free tissue transfer, can limit recovery in 
patients treated for head and neck cancer, with a curative intent.  The Patient Concerns 
Inventory (PCI-HN) is a prompt list that provides patients with repeated opportunities to raise 
issues they feel are important and want to discuss. Here, we look at baseline results from a 
cluster preference randomised control trial with consultants either ‘using’ or ‘not using’ the 
PCI package in clinic to identify patient concerns. UWQOL results were presented from 67 
consecutive patients having reconstruction with free tissue transfer  and PCI results from 25 
of these patients in the PCI arm of the trial. During early review consultations patients most 
wanted to discuss issues related to dental health, dry mouth and chewing.  Donor site 
morbidity, in our patient sample, did not appear to be an issue that patients wanted to discuss. 
 
Introduction 
Reconstruction with free tissue transfer is the gold standard in head and neck oncology1. It is 
difficult to assess the patient impact of the flap harvest; this may be due to the fact that 
patients may require neck dissections and adjuvant radiotherapy or may be due to the 
presence of other issues perceived as more important to discuss, in a busy clinic. There are 
several papers exploring donor site issues, with a variety of free flaps in routine use, in high 
volume centres. Some papers report specific issues, whilst others report insignificant 
concerns from the donor sites2-7. The post treatment Patient Concerns Inventory (PCI-HN) is 
a 57-item prompt list specific to head and neck cancer 8. Patients are able to select specific 
items and also have the opportunity through a free-text option to discuss with the clinicians 
any ‘other’ issue, that is not listed, such as donor site morbidity. The aim of this paper is to 
describe the overall health related quality of life (HRQOL) of patients having a free flap 
reconstruction and to assess how much the donor site forms part of what patients want to 
discuss during their early review consultations. 
Materials and Methods 
The protocol of the trial to assess the effectiveness of a consultation intervention package 
based around the PCI-HN used at routine follow-up clinics following treatment of head and 
neck cancer has been previously published9. The UW-QOL v4 questionnaire consists of 12 
single item domains, these having between 3 and 5 response options according to response 
hierarchy. UW-QOL domains are presented within two subscales, physical function and 
social-emotional function, as derived from earlier work10 .  Patients with head and neck 
defects were reconstructed with radial, anterolateral thigh, medial sural perforator and free 
flaps based on the thoracodorsal systems. 
Results 
A total of 67 patients in the trial had a free flap reconstruction from two tertiary centres, 35 
from Aintree and 32 from Leeds. There were 40 males and 27 females and their median 
(IQR) age at diagnosis was 64 (56-72) years. They attended trial baseline clinics  a median 
(IQR) 169 (97-223) days after surgery. Further patient characteristics are shown in Table 1. 
Figures 1 and 2 show the responses to the UWQOL for these 67 patients. 
 
A total of 25 patients in the PCI arm of the trial had a free flap reconstruction, 19 from 
Aintree and 6 from Leeds. There were 12 males and 13 females, and their median (IQR) age 
at diagnosis was 71 (63-76) years. They attended the trial baseline clinic  a median (IQR) 165 
(121-226) days after surgery.  Figure 3 illustrates the frequency of items as chosen by 
patients, at their baseline appointment with the clinical team. Donor site concerns were not 
raised on the PCI.  
Discussion 
The results in this short communication, are part of a larger cluster preference randomised 
controlled trial, that is currently ongoing. This is the first randomised trial in the literature 
reporting on issues patients would like to discuss at their first post-treatment consultation 
with the clinical team. Although direct questions about the donor site were not asked, it 
would be expected that if donor site issues had a significant effect on quality of life, then 
patients would be inclined to raise them voluntarily. Despite the plethora of papers reporting 
problems with the donor site, no patient from our sample wanted to discuss donor site 
problems. It is of interest that patients wanted to discuss issues related to dental health, dry 
mouth and chewing rather than wound healing (including the primary site) and cancer 
treatment. One explanation for these results may be that patients attended their first clinic 
several months (median 5.5 months) after the completion of surgery. It may be that donor site 
morbidity is relatively temporary in nature and may rarely be related with permanent 
functional defects. Literature is limited to the donor site morbidity of specific flaps or 
comparison between flaps. The difficulty in comparing donor site outcomes across various 
studies relates to unmatched populations and varying outcome criteria. Also, donor site 
morbidity will depend on the size of the flap harvested and this is often not taken into account 
in the literature. Health-related-quality-of-life results (Figures 1 and 2) generally indicate a 
reasonably good outcome given they have had  major reconstructive surgery.  The main 
issues concern the shoulder, mood, taste, saliva, swallowing and chewing and these do not 
relate to donor site morbidity.   
Donor site morbidity is one of the important factors in choosing a reconstructive option for an 
individual patient. Our results support the premise that surgeons should choose the most 
appropriate reconstruction for the defect as issues of donor site morbidity appear minimal 
relative to other concerns.  
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Table 1: Patient characteristics (Patient numbers and percentages) 
 All patients PCI patients* 
     
Surgery only                                                     21 31% 7 28% 
Surgery with radiotherapy 39 58% 16 64% 
Surgery with Radiotherapy and Chemotherapy 7 10% 2 8% 
Total 67  25  
     
Stage I 13 19% 3 12% 
Stage II 15 22% 7 28% 
Stage III 8 12% 4 16% 
Stage IV 31 46% 11 44% 
Total 67  25  
     
Oral cavity 60 90% 23 92% 
Oropharynx 5 8% 1 4% 
Larynx 1 2% 1 4% 
Other 1 2% 0  
Total 67  25  
 
*Patients in the PCI arm of the trial 
 
  
Figure 1: Response to the UWQOL (Social-Emotional function) by 67 patients having free flap 
reconstruction  
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Figure 2: Response to the UWQOL (Physical function) by 67 patients having free-flap reconstruction 
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Figure 3: Frequencies of issues that the 25 PCI patients wanted to discuss at their first post-treatment 
trial baseline consultation 
 
